Hecht Peter M 4
4 · Cyclerion Therapeutics, Inc. · Filed Dec 4, 2023
Insider Transaction Report
Form 4
Hecht Peter M
Director10% Owner
Transactions
- Award
Common Stock
2023-11-30+20,000→ 347,385 total - Award
Common Stock
2023-12-01+15,000→ 362,385 total
Holdings
- 24(indirect: By Trust)
Common Stock
- 24(indirect: By Trust)
Common Stock
- 24(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]The Reporting Person was granted 20,000 shares of restricted stock pursuant to the Cyclerion Therapeutics, Inc. 2019 Equity Incentive Plan. 2,500 of the shares vest immediately and the remaining 17,500 shares are subject to vesting ratably over a 42-month period, provided that the Reporting Person remains as a director of Cyclerion Therapeutics, Inc. on such applicable vesting date, subject to certain exemptions.
- [F2]The Reporting Person was granted 15,000 shares of restricted stock pursuant to the Cyclerion Therapeutics, Inc. 2019 Equity Incentive Plan. These 15,000 shares are subject to vesting over a 48- month period, provided that the Reporting Person remains a consultant to the Cyclerion Therapeutics or a member of the board of directors of Cyclerion Therapeutics, Inc. on such applicable vesting date, subject to certain exemptions.
- [F3]These shares are held in the referenced trust for the benefit of the reporting person's child. The reporting person's spouse is the trustee of this trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or any other purpose.